Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | |
| Sales | 1,736,356 | 703,784 |
| Cost of Goods | 364,892 | 187,145 |
| Gross Profit | 1,371,464 | 516,639 |
| Operating Expenses | 1,363,107 | 633,630 |
| Operating Income | 9,249 | -116,846 |
| Interest Expense | 5,276 | 2,641 |
| Other Income | 0 | -1,387,708 |
| Pre-tax Income | 3,973 | -1,507,195 |
| Income Tax | 20,414 | -262,083 |
| Net Income Continuous | -16,441 | -1,245,112 |
| Net Income | $-74,241 | $-1,245,112 |
| EPS Basic Total Ops | -0.07 | -1.22 |
| EPS Basic Continuous Ops | -0.02 | -1.22 |
| EPS Diluted Total Ops | -0.07 | -1.22 |
| EPS Diluted Continuous Ops | -0.02 | -1.22 |
| EBITDA(a) | $472,253 | $119,519 |